{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-179892","form_type":"8-K","ticker":"RPRX","cik":"0001802768","company_name":"Royalty Pharma plc","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.041849+00:00","generated_at":"2026-05-17T13:58:32.226934+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Henry Fernandez steps down as Lead Independent Director of Royalty Pharma board","bullets":["Fernandez resigned effective August 13, 2025, after five years on the board.","No disagreement with the company; departure is voluntary.","Board thanks Fernandez for his service and contributions.","Company intends to name a new Lead Independent Director in the near future."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-179892","json":"https://secwatch.observer/filing/0001193125-25-179892.json","markdown":"https://secwatch.observer/filing/0001193125-25-179892.md","text":"https://secwatch.observer/filing/0001193125-25-179892.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802768/000119312525179892/0001193125-25-179892-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802768/000119312525179892/d930454d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:58:32.226934+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}